ANI Pharmaceuticals (ANIP) earnings, Nov 5, 2026: EPS +32%, stock −2.8%
In brief
ANI Pharmaceuticals reported on Nov 5, 2026. Earnings per share changed +32% year over year, 23.6% above the estimate; revenue +28%. The stock opened with a +1.9% gap and closed the day −2.8% (Nov 5, 2026). The stock is now 27.2% below its 52-week high, −24.8% over 12 months.
EPS vs estimate+23.6%
EPS, YoY+32%
Revenue, YoY+28%
Gap · day+1.9% · −2.8%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Aug 7, 2026 | −6.7% | −5.3% |
| Nov 5, 2026 | +1.9% | −2.8% |
Next-quarter estimates, ratings and the ANIP chart are in the terminal.
Open the terminalFAQ
When is ANI Pharmaceuticals's next earnings report?
There is no new date in the data yet: companies announce it a few weeks ahead.
How did ANI Pharmaceuticals stock react to the report?
Opening gap +1.9%, day's result −2.8%.
Did ANI Pharmaceuticals's earnings grow?
Earnings per share rose 32% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.